NASDAQ:ACRS
$14.05
(
-1.95%
)
Friday, 3rd Feb 2023
Aclaris Therapeutics Stock Price (Quote)
| Range | Low Price | High Price | Comment |
|---|---|---|---|
| 30 days | $13.90 | $18.54 | Friday, 3rd Feb 2023 ACRS stock ended at $14.05. This is 1.95% less than the trading day before Thursday, 2nd Feb 2023. During the day the stock fluctuated 9.71% from a day low at $13.90 to a day high of $15.25. |
| 90 days | $13.90 | $18.96 | |
| 52 weeks | $9.84 | $18.96 |
Historical Aclaris Therapeutics prices
| Date | Open | High | Low | Close | Volume |
| 2023-02-03 | $14.81 | $15.25 | $13.90 | $14.05 | 1 890 024 |
| 2023-02-02 | $17.03 | $17.61 | $14.22 | $14.33 | 1 991 082 |
| 2023-02-01 | $16.89 | $17.15 | $16.22 | $16.97 | 650 028 |
| 2023-01-31 | $16.88 | $17.51 | $16.73 | $16.90 | 472 620 |
| 2023-01-30 | $17.67 | $18.54 | $16.70 | $16.85 | 448 703 |
| 2023-01-27 | $16.75 | $17.68 | $16.70 | $17.48 | 1 016 459 |
| 2023-01-26 | $16.95 | $17.10 | $16.59 | $16.82 | 402 417 |
| 2023-01-25 | $16.18 | $16.98 | $16.00 | $16.77 | 496 682 |
| 2023-01-24 | $16.56 | $16.83 | $16.07 | $16.40 | 473 206 |
| 2023-01-23 | $16.63 | $16.68 | $16.13 | $16.59 | 323 449 |
| 2023-01-20 | $17.02 | $17.02 | $16.20 | $16.65 | 306 644 |
| 2023-01-19 | $17.16 | $17.16 | $16.36 | $16.68 | 239 201 |
| 2023-01-18 | $17.97 | $18.24 | $17.18 | $17.23 | 326 200 |
| 2023-01-17 | $17.89 | $18.13 | $17.32 | $17.90 | 823 200 |
| 2023-01-13 | $17.54 | $18.48 | $17.54 | $17.95 | 432 907 |
| 2023-01-12 | $16.54 | $17.72 | $16.34 | $17.63 | 232 200 |
| 2023-01-11 | $17.27 | $17.43 | $16.20 | $16.54 | 209 000 |
| 2023-01-10 | $16.31 | $17.32 | $16.31 | $17.25 | 214 723 |
| 2023-01-09 | $16.71 | $16.76 | $16.22 | $16.31 | 218 249 |
| 2023-01-06 | $15.34 | $16.64 | $15.21 | $16.55 | 327 500 |
| 2023-01-05 | $14.77 | $15.56 | $14.65 | $15.23 | 284 080 |
| 2023-01-04 | $15.24 | $15.30 | $14.65 | $14.97 | 265 948 |
| 2023-01-03 | $15.93 | $16.53 | $14.89 | $15.07 | 348 167 |
| 2022-12-30 | $16.13 | $16.58 | $15.72 | $15.75 | 326 150 |
| 2022-12-29 | $15.63 | $16.40 | $15.15 | $16.13 | 178 986 |
| 2022-12-28 | $15.11 | $15.67 | $14.99 | $15.49 | 256 199 |
| 2022-12-27 | $15.12 | $15.65 | $14.98 | $15.03 | 178 273 |
| 2022-12-23 | $15.30 | $15.34 | $14.91 | $15.08 | 288 756 |
| 2022-12-22 | $14.98 | $15.36 | $14.86 | $15.29 | 332 711 |
| 2022-12-21 | $15.12 | $15.48 | $14.87 | $15.00 | 260 740 |
| 2022-12-20 | $14.56 | $15.24 | $14.47 | $15.04 | 254 720 |
| 2022-12-19 | $15.45 | $15.45 | $14.02 | $14.60 | 395 295 |
| 2022-12-16 | $15.50 | $15.93 | $15.05 | $15.59 | 665 219 |
| 2022-12-15 | $15.96 | $16.19 | $15.55 | $15.65 | 251 910 |
| 2022-12-14 | $16.33 | $16.92 | $15.94 | $16.17 | 469 892 |
| 2022-12-13 | $15.99 | $16.29 | $15.80 | $15.94 | 323 982 |
| 2022-12-12 | $15.22 | $16.02 | $15.18 | $15.59 | 363 922 |
| 2022-12-09 | $15.46 | $15.56 | $15.07 | $15.16 | 236 427 |
| 2022-12-08 | $15.21 | $15.65 | $14.95 | $15.51 | 214 837 |
| 2022-12-07 | $15.93 | $16.38 | $15.13 | $15.18 | 251 353 |
| 2022-12-06 | $15.57 | $16.29 | $15.31 | $15.92 | 362 417 |
| 2022-12-05 | $16.44 | $16.93 | $15.34 | $15.65 | 391 113 |
| 2022-12-02 | $15.72 | $16.71 | $15.72 | $16.64 | 435 118 |
| 2022-12-01 | $15.46 | $16.08 | $15.32 | $15.86 | 678 067 |
| 2022-11-30 | $15.90 | $16.17 | $15.01 | $15.22 | 683 457 |
| 2022-11-29 | $17.17 | $17.50 | $15.72 | $15.79 | 344 737 |
| 2022-11-28 | $17.41 | $17.68 | $16.85 | $16.99 | 195 970 |
| 2022-11-25 | $17.71 | $17.86 | $17.44 | $17.53 | 65 539 |
| 2022-11-23 | $17.79 | $18.14 | $17.55 | $17.70 | 269 025 |
| 2022-11-22 | $18.32 | $18.32 | $17.66 | $17.94 | 351 000 |
About Aclaris Therapeutics
Aclaris Therapeutics, Inc. operates a clinical-stage biopharmaceutical company, develops novel drug candidates for immune-inflammatory diseases in the United States. It operates through two segments: Therapeutics and Contract Research. The Therapeutics segment is involved in identifying and developing innovative therapies to address significant unmet needs for immuno-inflammatory diseases. The Contract Research segment engages in the provision of... ACRS Profile
Top Fintech Company
featured in The Global Fintech Index 2020 as the top Fintech company of the country.
